|
97
|
300
|
9grpA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and beta-chloroethyl theophylline |
|
90
|
301
|
9gufA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54571106 |
|
90
|
301
|
9gueA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 57256189 |
|
75
|
305
|
9hdcA |
Sars-cov-2 main protease in complex with (3s)-3-[(3r)-3-phenylpiperidine-1-carbonyl]indan-1-one |
|
80
|
305
|
9hc1A |
Sars-cov-2 main protease complexed with (1r)-n-(3-chlorophenyl)-3-oxo-n-[4-(2-oxopyrrolidin-1-yl)phenyl]indane-1-carboxamide |
|
93
|
301
|
9guyB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54571098 |
|
26
|
115
|
9guyC |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54571098 |
|
84
|
301
|
9gtfA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 57256190 |
|
26
|
116
|
9gudB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54570922 |
|
88
|
301
|
9gudA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54570922 |
|
28
|
116
|
9gueB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 57256189 |
|
85
|
303
|
9gijA |
Crystal structure of sars-cov-2 mpro with compound 5 |
|
31
|
115
|
9grpB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and beta-chloroethyl theophylline |
|
24
|
116
|
9gufB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54571106 |
|
28
|
115
|
9grqB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline |
|
77
|
305
|
9hdjA |
Sars-cov-2 main protease in complex with (3r)-3-[(3r)-4-benzyl-3-phenyl-piperidine-1-carbonyl]indan-1-one |
|
74
|
305
|
9hbqA |
Sars-cov-2 main protease complexed with (1r)-n-(3-chlorophenyl)-3-oxo-indane-1-carboxamide |
|
89
|
302
|
9glvA |
Crystal structure of sars-cov-2 mpro with ab-343. |
|
28
|
115
|
9gwoB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54571126 |
|
95
|
300
|
9gwoA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54571126 |
|
93
|
301
|
9gs4A |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54571130 |
|
92
|
300
|
9gnyA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and caffeine |
|
90
|
306
|
9hakA |
Structure of compound 119 bound to sars-cov-2 main protease |
|
98
|
300
|
9grqA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline |
|
23
|
116
|
9gtfB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 57256190 |
|
89
|
306
|
9gilA |
Crystal structure of sars-cov-2 mpro with compound 12 |
|
79
|
306
|
9hdnA |
Sars-cov-2 main protease in complex with (1r)-3-oxo-n-[2-oxo-2-(n-phenylanilino)ethyl]indane-1-carboxamide |
|
25
|
115
|
9gnyB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and caffeine |
|
29
|
115
|
9gs4B |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and theophylline derivative las 54571130 |
|
93
|
344
|
9fiuA |
Structure-guided discovery of selective usp7 inhibitors with in vivo activity |
|
91
|
344
|
9fitA |
Structure-guided discovery of selective usp7 inhibitors with in vivo activity |
|
90
|
346
|
9fioA |
Structure-guided discovery of selective usp7 inhibitors with in vivo activity |
|
92
|
344
|
9fipA |
Structure-guided discovery of selective usp7 inhibitors with in vivo activity |
|
96
|
343
|
9fivA |
Structure-guided discovery of selective usp7 inhibitors with in vivo activity |
|
89
|
705
|
9fcjD |
Usp1 bound to ml323 and ubiquitin conjugated to fancd2 (ordered subset, focused refinement) |
|
90
|
344
|
9fisA |
Structure-guided discovery of selective usp7 inhibitors with in vivo activity |
|
74
|
701
|
9fciD |
Usp1 bound to ksq-4279 and ubiquitin conjugated to fancd2 (focused refinement) |
|
94
|
344
|
9firA |
Structure-guided discovery of selective usp7 inhibitors with in vivo activity |
|
90
|
340
|
9fiqA |
Structure-guided discovery of selective usp7 inhibitors with in vivo activity |
|
88
|
306
|
9eoxA |
Sars-cov2 major protease in covalent complex with a soluble inhibitor. |
|
90
|
306
|
9eorA |
Sars-cov2 major protease in complex with a covalent inhibitor sll12. |
|
91
|
306
|
9eo6A |
Sars-cov2 major protease in complex with a covalent inhibitor sll11. |
|
82
|
298
|
9dw6A |
Crystal structure of sars-cov-2 main protease (mpro) c145a mutant in complex with peptide from human trna methyltransferase trmt1 |
|
89
|
313
|
9csyA |
Sars-cov-2 papain-like protease (plpro) bound to pf-07957472 |
|
84
|
306
|
9cmjA |
Room-temperature x-ray structure of sars-cov-2 main protease drug resistant mutant (l50f, e166v) |
|
86
|
306
|
9cmnA |
Room-temperature x-ray structure of sars-cov-2 main protease drug resistant mutant (e166a, l167f) |
|
86
|
301
|
9cmsA |
Room-temperature x-ray structure of sars-cov-2 main protease drug resistant mutant (e166v) in complex with ensitrelvir (esv) |
|
84
|
304
|
9cmuA |
Room-temperature x-ray structure of sars-cov-2 main protease drug resistant mutant (l50f, e166v) in complex with ensitrelvir (esv) |
|
87
|
305
|
9c8qA |
Co-structure of main protease of sars-cov-2 (covid-19) with covalent inhibitor |
|
88
|
302
|
9c80A |
Co-structure of sars-cov-2 (covid-19 with covalent inhibitor |
